この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2019/5/21 分で読めます
Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients; Public Workshop; Request for Comments
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Development of Antiviral Drugs for the Treatment of Adenoviral Infection in Immunocompromised Patients." The purpose of the public workshop is to discuss the scientific and clinical trial design considerations for development of antiviral products to treat adenoviral infection.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →